Nifty Pharma Prediction for Monday: Index Adds to 24,460.30 Before Fed Day, Outlook for Monday 22 June 2026

The nifty pharma prediction for monday, Monday 22 June 2026, sees Nifty Pharma extend gains after closing at 24,460.30, up 0.73 percent today. Pharma is rate-cycle agnostic; the hawkish Fed does not hurt specialty pipeline earnings, making it the ideal Monday defensive carry from Friday’s rotation.

Ankit Jaiswal, Senior Research Analyst at Univest, breaks down the nifty pharma prediction for monday with the levels that matter, the F&O signals and the events that decide Wednesday, the day the US Fed decision lands.

Click Here – Get Free Investment Predictions

How Today Set Up the Nifty Pharma Prediction for Monday

The index moved up 0.73 percent today to 24,460.30, in a session where the broader market ground higher and held near its highs ahead of the Fed. Pharma gained 0.73 percent on Friday, the second-best sector of the day, as defensive rotation powered Sun Pharma to fresh highs. That backdrop frames the nifty pharma prediction for monday.

Key Levels for the Nifty Pharma Prediction for Monday

Level	Value
Today’s close	24,460.30 (+0.73%)
Day range	24,274.40 to 24,493.85
Pivot (Wed)	24,410
Resistance R1 / R2	24,545 / 24,629
Support S1 / S2	24,325 / 24,190
India VIX	13.39

The pivot for Wednesday sits at 24,410, with resistance at 24,545 and 24,629 and support at 24,325 and 24,190. These levels anchor the nifty pharma prediction for monday.

Constituents That Moved Today

Stock	LTP (Rs)	Change
Sun Pharma	1,820.40	+1.42%
Cipla	1,385.00	+0.22%
Dr Reddys	1,275.00	+0.39%

Sun Pharma leads the watch list, and the spread above is what traders track for the nifty pharma prediction for monday into the Fed-day session.

F&O and Derivatives Signals for the Nifty Pharma Prediction for Monday

Nifty Pharma has no single liquid index future, so the F&O read for the nifty pharma prediction for monday comes from its most active constituents.

• Stock F&O proxy: The derivatives tone is set by the heavyweight constituents, led by Sun Pharma, whose stock futures and options lead the index
• Open interest signal: Watch open interest in Sun Pharma and Cipla, Dr Reddys: rising OI with rising price is conviction, rising OI with falling price flags fresh shorts
• How to use it: For a sector without its own future, long build-up versus short build-up in the lead names is the cleanest gauge of where the index goes next
• Options picture: Option activity in those names marks the practical support and resistance for the nifty pharma prediction for monday into the Fed

What Will Drive the Nifty Pharma Prediction for Monday

• Sector trigger: Pharma is rate-cycle agnostic; the hawkish Fed does not hurt specialty pipeline earnings, making it the ideal Monday defensive carry from Friday’s rotation.
• Post-Fed Monday: Markets have had the weekend to absorb the hawkish Fed that removed the last rate cut projection; Monday opens a fresh settlement week with no major domestic events
• IT correction watch: Nifty IT fell 3.65 percent on Friday as Infosys shed 6.75 percent and TCS 3.55 percent; whether IT stabilises or extends the fall is Monday’s primary domestic variable
• Sensex weekly expiry: Monday 22 June is the Sensex weekly options expiry, stacking expiry pin-risk on top of the Fed reaction in the same session
• VIX at week-low: India VIX fell to 12.77 on Friday, the week’s lowest reading, suggesting the broader market is calm heading into Monday despite the IT correction

Track All Nifty Pharma Stocks Live on the Univest Screener

Trading Strategy for Monday

The nifty pharma prediction for monday favours a disciplined, level-based approach into a Fed-day session.

• Watch the pivot: Holding above 24,410 keeps the bias positive, a slip below shifts it to the 24,325 support
• Let the Fed lead: With the statement due Wednesday night, intraday moves may stay muted until the decision, so avoid forcing trades into the event
• Resistance to clear: 24,545 is the first ceiling, a sustained move above opens 24,629
• Size for the event: A binary catalyst like the Fed rewards smaller positions and defined risk over conviction

Nifty Pharma Prediction for Monday: Quick Answers

Nifty Pharma outlook for Monday: Constructive into the Fed, pivot 24,410, resistance 24,545, support 24,325.

Key resistance and support: Resistance 24,545 and 24,629, support 24,325 and 24,190.

The big event: The US Fed statement late Wednesday night India time under new Chair Kevin Warsh.

Download the Univest iOS App or Univest Android App to track the nifty pharma prediction for monday with live levels and daily research from Univest analysts.

Conclusion

The nifty pharma prediction for monday, 18 June 2026, is for a constructive on banking and defensive momentum session. With the index at 24,460.30, the pivot at 24,410 is the line to watch, resistance sits at 24,545 and support at 24,325, with the Fed decision the catalyst that resolves the coil. Univest analysts will refresh the nifty pharma prediction for monday as the decision lands. Check back for the next update.

FAQs on the Nifty Pharma Prediction for Monday

What is the nifty pharma prediction for Monday, 22 June 2026?

Ans. The nifty pharma prediction for monday is for a constructive but range-bound session before the Fed. The index closed at 24,460.30 +0.73 percent today, with the Wednesday pivot at 24,410, resistance at 24,545 and support at 24,325. The US Fed decision lands late Wednesday night India time.

What are the key levels for Nifty Pharma Monday?

Ans. The Wednesday pivot is 24,410. Resistance sits at 24,545 and 24,629, while support is at 24,325 and 24,190. Today’s range was 24,274.40 to 24,493.85.

What do the F&O signals say for Nifty Pharma Monday?

Ans. Nifty Pharma has no single index future, so the F&O read comes from heavyweight constituents like Sun Pharma, where long versus short build-up leads the index. Rising open interest with rising price signals conviction.

What will drive Nifty Pharma Monday?

Ans. Pharma is rate-cycle agnostic; the hawkish Fed does not hurt specialty pipeline earnings, making it the ideal Monday defensive carry from Friday’s rotation. Above that, the US Fed statement late Wednesday night under new Chair Kevin Warsh is the dominant event for the nifty pharma prediction for monday, with India VIX unusually low at 13.39 going in.

Who provides the Univest view on the nifty pharma prediction for Monday?

Ans. Ankit Jaiswal, Senior Research Analyst at Univest provides the view, with Univest analysts tracking the index levels, F&O positioning and the Fed through the session.